One-Pager

Electrolyte Imbalances

Na, K, Ca, Mg and phos: normals, ECG clues, safe replacement, hyperkalemia steps

Reviewed by Alex G, BSN, RN, CEN, CCRN, CMC, NREMT-P · Checked against current sources October 2026

Download one-page PDFLetter landscape, ready to print or keep with your notes

Normals and key signs

Exam study summary, not a bedside tool. Doses are typical adult ranges; follow your institution's protocols.

Typical adult ranges (MedlinePlus; ionized Ca from Merck). Labs and exams vary: many review books use Ca 9.0–10.5 and Mg 1.3–2.1 mEq/L.
IonNormalLowHigh
Na135–145 mEq/LNausea, confusion, seizuresThirst, confusion, seizures
K3.5–5.0 mEq/LWeakness; flat T, U wave, ST sagWeakness; peaked T, wide QRS
Ca8.8–10.3 mg/dL; ionized 4.7–5.2 mg/dL (1.17–1.30 mmol/L)Tetany, Chvostek, Trousseau; long QTStones, constipation, confusion; short QT
Mg1.7–2.2 mg/dLTremor, tetany; long QT, torsadesLost reflexes, slow breathing, long PR
Phos2.8–4.5 mg/dLWeakness, failure to wean, hemolysisLow-Ca signs (tetany, long QT)

Hyperkalemia: stabilize, shift, remove

Lead II · 25 mm/s
Hyperkalemia: peaked T, flat P, wide QRS; can end in sine wave, VF or asystole.
  1. Stabilize (ECG changes): calcium gluconate 10% 30 mL over 10 min; in arrest or peri-arrest, calcium chloride 10% 10 mL over 5 min (same calcium). Acts in about 3 min, lasts 30–60 min; repeat if changes persist.
  2. Shift: regular insulin 10 units IV with dextrose 25–50 g. K falls within 15 min, lowest at 30–60 min.
  3. Add-on shift: nebulized albuterol 10–20 mg, never alone. Bicarbonate mainly for metabolic acidosis.
  4. Remove: binders (sodium zirconium cyclosilicate acts in about 1 h, patiromer 4–7 h), loop diuretic, dialysis (definitive).
  5. Recheck K often; it rebounds as the shift wears off.

In cardiac arrest (AHA 2025), calcium, bicarbonate and insulin-glucose may be considered but are unproven; inhaled albuterol is not recommended.

Potassium and magnesium replacement

Lead II · 25 mm/s
Torsades: polymorphic VT twisting around the baseline, set up by a long QT.

Calcium: salts and corrected calcium

FeatureGluconate 10%Chloride 10%
Elemental Ca per 10 mLAbout 93 mgAbout 270 mg (3 times more)
LinePeripheral OK (secure IV)Central or deep vein; necrosis if it leaks

Corrected Ca = Ca + 0.8 × (4.0 − albumin g/dL). Example: Ca 7.6, albumin 2.0 → 9.2 mg/dL, not truly low.

Low ionized Ca: alkalosis, massive transfusion (citrate), thyroid or parathyroid surgery, pancreatitis.

High Ca: IV saline first. If severe (over 14 mg/dL), calcitonin (fast, fades in 48–72 h) plus an IV bisphosphonate or denosumab (slower, longer acting).

Sodium: correct slowly

Causes, refeeding, phosphate

Practice Electrolyte Imbalances questions free in your browser43 exam-style questions with rationales. No account or download needed.

In depth

The one-page summary above is what the PDF prints. These sections go further.

Sodium, water and tonicity

Serum Na measures water balance, not body sodium: Na ≈ (exchangeable Na + K) ÷ total body water (Edelman). Low Na almost always means ADH is stopping the kidney from excreting water; high Na means water losses outran intake in someone who cannot drink. Because K is in the numerator, KCl raises Na much as NaCl does.

Tonicity (effective osmolality) = 2 × Na + glucose ÷ 18; urea and ethanol cross cell membranes, so they raise measured osmolality without moving water. ADH release starts near 280 mOsm/kg and thirst near 290 (European guideline 2014). A 5% fall in blood pressure also raises ADH, as do nausea, pain, anesthesia and many drugs.

Water excretion is limited by solute: maximum urine volume ≈ solute intake ÷ minimum urine osmolality (about 50 mOsm/kg). A beer or tea-and-toast diet of 250 mOsm/day allows only 5 L of urine, so drinking more lowers Na even without ADH.

Over 24–48 h, brain cells shed electrolytes and organic osmolytes to undo swelling (European guideline 2014). That sets the 48 h line between acute and chronic hyponatremia and makes fast correction dangerous: osmolytes return slowly, so a quick rise shrinks adapted cells and strips myelin. In hypernatremia the risk is reversed: cerebral edema.

Hyponatremia: work-up by urine and volume

Send urine osmolality and Na with the serum sample, before saline or diuretics change them. The European guideline (2014) works in this order: serum osmolality under 275 mOsm/kg confirms hypotonicity; urine osmolality 100 or less means intake exceeds maximal excretion (polydipsia, beer potomania); above 100, urine Na 30 mEq/L or less means low effective arterial volume. Volume status comes last because bedside assessment is unreliable.

Older US teaching uses a urine Na cutoff of 20. With vomiting and alkalosis, use urine Cl instead (Merck).
VolumeUrine NaCausesFirst step
Low, extrarenalUnder 30Diarrhea, vomiting, burns, third spacingIsotonic saline or balanced fluid
Low, renalOver 30Thiazides, salt wasting, adrenal insufficiencySaline; stop the drug; hydrocortisone
NormalOver 30SIADH, hypothyroidism, low cortisolRestrict water; treat the cause
Normal, dilute urineOften lowPolydipsia, low solute intakeStop excess water; add solute
HighUnder 30 off diureticsHeart failure, cirrhosis, nephrotic syndromeRestrict water; loop diuretic

SIADH is a diagnosis of exclusion: effective osmolality under 275, urine osmolality over 100, euvolemia, urine Na over 30, normal adrenal, thyroid and kidney function, and no recent diuretic; uric acid under 4 mg/dL supports it (European guideline 2014). ICU causes: pneumonia, positive-pressure ventilation, SAH, head trauma, pain, nausea, SSRIs, carbamazepine, opioids, cyclophosphamide, vasopressin analogues.

Cerebral salt wasting shares the labs but adds volume depletion and high urine output; it needs salt and volume. After SAH, fluid restriction raises the risk of delayed ischemia, so it is avoided even when SIADH is likely. In SIADH, 0.9% saline lowers Na further when urine Na + K exceeds 154 mEq/L: the salt leaves in less water than it came in with.

Hyponatremia: correction limits and overcorrection rescue

Severe symptoms (vomiting, seizures, deep somnolence, coma) need 3% saline now, acute or chronic: Europe 2014 gives 150 mL over 20 min, repeated up to twice until Na has risen 5 mEq/L; Merck gives 100 mL over 15 min. In SALSA (2021, 178 patients), boluses reached target sooner than slow infusion without more overcorrection. Then stop 3% and treat the cause.

Limits, not targets: the US panel aims for 4–8 per day, 4–6 if high risk.
SourceLimit (mEq/L)High ODS risk
Europe 201410 in the first 24 h, then 8 per 24 hNo separate limit
US panel 201310–12 in any 24 h; 18 in any 48 h8 in any 24 h
Merck 20258 in the first 24 hNo separate limit

High ODS risk (US panel 2013): Na 105 or less, hypokalemia, alcohol use disorder, malnutrition, liver disease. In a 2025 meta-analysis (Kidney Med; 26,710 patients), ODS occurred in 0.23% overall and 2.9% with Na under 116; correction over 8 mEq/L in 24 h tripled the odds, yet about a third of cases had no rapid correction.

Overcorrection usually comes from the patient: once the ADH stimulus ends (volume restored, thiazide stopped, cortisol given, nausea relieved), dilute urine pours out. With Na under 120, the rise beat the Adrogué–Madias formula (next section) in 74% of patients, by 2.4 times on average (Europe 2014). Rising urine output with falling specific gravity means check Na now.

  1. Trigger (Europe 2014): Na up more than 10 in the first 24 h or 8 in any later 24 h; stop all sodium-raising treatment.
  2. With expert advice, give D5W 10 mL/kg over 1 h, with strict intake and output.
  3. Add desmopressin 2 mcg IV, no more often than every 8 h, to stop the water diuresis.

The desmopressin clamp gives desmopressin 1–2 mcg IV or SC every 6–8 h with slow 3% saline and no free water, so Na rises only with the sodium given (Sood 2013: 5.8 mEq/L in 24 h, no overcorrection). Evidence is mixed: proactive use cut overcorrection from 27.1% to 6.8% in a 2025 cohort (AlShanableh), but a 49-patient trial found no significant difference (Pakchotanon 2024). Any free water on desmopressin drops Na.

Chronic SIADH: restrict fluid first; restriction cannot work when urine Na + K exceeds serum Na (Furst 2000). Second line (Europe 2014): urea 0.25–0.50 g/kg/day or a loop diuretic with oral salt. Tolvaptan starts in hospital, with no fluid restriction for 24 h, for at most 30 days (label: liver injury); Europe advises against vaptans. Hypovolemia: 0.9% saline or balanced fluid at 0.5–1 mL/kg/h (Europe 2014).

Hypernatremia and the free water deficit

Hypernatremia is always hypertonic and nearly always a water deficit in someone who cannot drink. ICU causes: fever, osmotic diuresis (glucose, mannitol, high-protein feeds), loop diuretics, lactulose and sodium loads (bicarbonate, hypertonic saline).

Free water deficit = TBW × (Na ÷ 140 − 1), with TBW 0.6 × weight in younger men, 0.5 in younger women and older men, 0.45 in older women (Europe 2014). An 80 kg man with Na 162: TBW 48 L, deficit about 7.5 L. Lowering Na by 10 in a day takes 48 × (162 ÷ 152 − 1) ≈ 3.2 L plus ongoing losses. Adrogué–Madias gives the change per liter as (infusate Na + K − serum Na) ÷ (TBW + 1): D5W lowers his Na about 3.3 mEq/L per liter (162 ÷ 49), 0.45% saline about 1.7.

Merck lowers chronic or unknown-duration hypernatremia over 48 h at no more than 0.5 mEq/L/h; Adrogué and Madias (2000) target 10 mEq/L per day, faster if the rise took hours. In Chauhan 2019 (449 ICU patients, Na over 155), the 154 corrected faster than that had no excess mortality or cerebral edema. Exams still expect slow correction.

Give water enterally when possible; D5W is pure free water (watch glucose) and 0.45% saline is half. In shock, restore perfusion first: 0.9% saline is still hypotonic to a Na of 160. Treat the cause: desmopressin for central DI; stop lithium and correct Ca and K for nephrogenic DI.

Potassium: shifts, losses and replacement

A 70 kg adult holds about 3,500 mEq of K, 98% inside cells (Merck). Insulin, beta-2 agonists and alkalosis drive K in; hyperosmolality, normal-gap acidosis, cell lysis, digoxin toxicity and succinylcholine move it out, while lactic and ketoacidosis shift little (Merck). Secretion in the collecting duct needs aldosterone, distal sodium delivery and urine flow, so ACE inhibitors, spironolactone, trimethoprim, heparin and oliguria raise K, and loop or thiazide diuretics and vomiting lower it.

Each 1 mEq/L fall reflects a loss of about 200–400 mEq (Merck), so a K of 2.5 can need 300–600 mEq over days. Shift hypokalemia (insulin, beta agonists, hypothermia, thyrotoxic periodic paralysis) is the exception: replacement overshoots when the shift reverses, as on rewarming after cooling. Urine K over 15 mEq/L points to renal loss (Merck).

UKKA 2026 grades high K as mild (5.5–5.9), moderate (6.0–6.4) or severe (6.5 or more) and monitors severe cases continuously. Insulin 10 units with 25 g glucose lowers K by 0.65–1.4 mEq/L, and up to 40% of patients with end-stage kidney disease do not respond to salbutamol. Besides hemolysis, pseudohyperkalemia comes from fist clenching, thrombocytosis and extreme leukocytosis (Merck); a blood gas K is a quick check.

Calcium: ionized vs total, PTH, citrate and malignancy

About 40% of serum Ca is protein-bound, mostly to albumin, about half is ionized and the rest complexed (Merck); only ionized Ca acts. Alkalosis binds Ca to albumin, so hyperventilation or bicarbonate lowers iCa with total Ca unchanged. In Özdemir 2026 (250 ICU patients), albumin-corrected Ca caught only 15.2% of low iCa, uncorrected total Ca 62.8%.

A fall in iCa raises PTH within minutes: Ca leaves bone, the kidney keeps Ca and wastes phosphate, and activated vitamin D raises gut absorption over days. Mg under about 1.0 mg/dL blocks PTH release and action (Merck), so replace Mg first. Beyond the one-pager's list, low iCa follows sepsis, CRRT citrate, tumor lysis and rhabdomyolysis.

The liver clears citrate in minutes, but shock, hypothermia and liver failure slow it, so iCa falls during large transfusions (Merck: over 10 units): measure iCa often and keep it normal. For symptoms, give calcium gluconate 10% 10 mL over 10 min, then 20–30 mL in 1 L D5W over 12–24 h (Merck). Gluconate needs no liver: both salts raised iCa equally in anhepatic patients (Martin 1990). Treating mild ionized hypocalcemia has no proven benefit (Cochrane, Forsythe 2008), so thresholds vary.

High Ca comes mostly from hyperparathyroidism (PTH high or normal) or cancer (PTH suppressed). In cancer, PTH-related peptide causes about 80%, bone metastases or myeloma about 20%, and lymphoma calcitriol under 1% (Stewart 2005). It blocks urine concentration, so patients arrive dry: fluid comes first. Severe is over 14 mg/dL (Endocrine Society 2023).

Endocrine Society 2023 unless marked Merck. The Society suggests denosumab over a bisphosphonate and finds little evidence for furosemide, which Merck adds after rehydration.
TreatmentDoseOnsetNotes
Isotonic saline1–2 L over 2–4 h, then urine about 250 mL/h (Merck)HoursTailor to cardiac function
Calcitonin4–8 units/kg IM or SC every 6–12 h4–6 h; Ca falls 1–2 mg/dLTachyphylaxis; limit to 48–72 h
Zoledronic acid4 mg IV over at least 15 min (label)48–72 hNo cut for creatinine under 4.5 (label); check it each dose
Denosumab120 mg SC3–10 daysHypocalcemia risk if GFR under 30
GlucocorticoidsPrednisone 40–60 mg/day (Merck)DaysCalcitriol-driven: lymphoma, granulomas
HemodialysisLow-calcium dialysateHoursCa over 18 mg/dL or severe symptoms (Merck)

Magnesium, phosphate and refeeding

About 1% of body Mg is in serum, so a normal level does not exclude depletion. Causes: loop and thiazide diuretics, PPIs, alcohol, diarrhea, amphotericin, cisplatin, calcineurin inhibitors, refeeding and CRRT. Low cell Mg releases its brake on ROMK channels, so the distal nephron wastes K until Mg is restored (Huang 2007).

Merck gives magnesium sulfate 2–4 g IV over 5–10 min for seizures or arrhythmia (AHA uses 1–2 g for torsades), otherwise about 1 g/h for up to 10 h, because about half of an IV dose is lost in urine; give less in kidney failure. High Mg (Merck): ECG changes at 6–12 mg/dL, reflexes lost near 12, then hypotension and respiratory depression, arrest above 15. Give calcium gluconate 10% 10–20 mL IV, and dialysis if the kidneys have failed.

Phosphate builds ATP and 2,3-DPG. Low levels (severe under 1 mg/dL, Merck) come from shifts (refeeding, insulin, respiratory alkalosis), CRRT losses, burns and alcohol use disorder. Effects: diaphragm weakness and failure to wean, poor contractility, rhabdomyolysis, hemolysis and a left-shifted oxyhemoglobin curve. In Aubier 1985, 8 ventilated patients generated more diaphragm pressure after 10 mmol of phosphate over 4 h.

Potassium phosphates label (2025): at most 45 mmol per dose, 6.8 mmol/h peripherally, 15 mmol/h centrally; use sodium phosphate if K is 4 or more.
Serum phos (mg/dL)IV phosphate doseK delivered
1.8 to low normal0.16–0.31 mmol/kg0.23–0.46 mEq/kg
1.0–1.70.32–0.43 mmol/kg0.47–0.63 mEq/kg
Under 1.00.44–0.64 mmol/kg0.64–0.94 mEq/kg

Normalize Ca first and never run phosphate with calcium (label). In kidney failure, tumor lysis or rhabdomyolysis, high phosphate binds Ca; precipitation is likely once Ca × phos exceeds about 70 (Merck).

Refeeding syndrome (ASPEN 2020) is a fall in phos, K or Mg of 10–20% (mild), 20–30% (moderate), or over 30% or with organ dysfunction (severe) within 5 days of restarting calories. High risk includes BMI under 16 or little intake for over 7 days.

Electrolytes on the ECG

K and Mg thresholds from Merck; levels and ECG often disagree.
DisturbanceECGRhythm risk
K over 5.5Tall peaked T; PR lengthensRises with level and speed of rise
K over 6.5Wide QRS; P waves fadeJunctional and escape rhythms, bradycardia
Severe high KSine waveVF, asystole; pacing may fail
Low KFlat T, ST sag, U wave, long QUPVCs, VT, torsades; digoxin toxicity
Low MgLong QTTorsades; digoxin toxicity
Low CaLong QT from a long ST segmentTorsades is rare
High CaShort QT (short ST segment)Bradycardia, AV block
High Mg 6–12 mg/dLLong PR, wide QRS, taller THeart block; arrest over 15 mg/dL

The ECG rules high K in, not out: in the study UKKA 2026 cites, sensitivity was 0.19 and specificity 0.97, and the first sign can be VF or asystole. QRS widening, heart rate under 50 and junctional rhythm predict adverse events; that bradycardia may resist atropine and pacing, pacemakers can malfunction above about 7 mEq/L, and IV calcium can raise the rate (UKKA 2026).

Low K, low Mg and QT-prolonging drugs add up to torsades. Repeat the ECG after each corrective step.

Dialysis, CRRT and safe replacement

Hemodialysis removes 70–100 mEq of K per session; serum K falls about 1 mEq/L in the first hour and 1 more over the next 2 hours, then rebounds as cells release K, more after insulin or salbutamol (UKKA 2026). Give IV calcium for ECG changes even when dialysis is about to start. CRRT lowers K more slowly but with less rebound; K follows the bag (0, 2 or 4 mEq/L).

On CRRT, phosphate-free fluid causes hypophosphatemia in most patients by day 2–3, Mg is lost (more on citrate), and citrate accumulation shows as falling iCa with rising total Ca, a total-to-ionized ratio of 2.5 or more (CRRT sheet). Dialysis pulls Na toward the fluid's 140, so chronic hyponatremia can overcorrect within hours; units lower the fluid Na, by methods that vary.

Exam pearls

Practice free in your browser2,150+ exam-style questions with rationales. No account, no ads. Also free on the App Store and Google Play.

Related one-pagers

Calculators for this topic

Sources

  1. Alfonzo A, Harrison A, Baines R, Chu A, Mann S, MacRury M. Clinical Practice Guidelines: Treatment of Acute Hyperkalaemia in Adults. UK Kidney Association; original July 2020, updated October 2023, updated July 2026 (review date October 2026). Link
  2. Part 10: Adult and Pediatric Special Circumstances of Resuscitation: 2025 American Heart Association Guidelines for CPR and ECC. Circulation. 2025. doi:10.1161/CIR.0000000000001380 Link
  3. Part 9: Adult Advanced Life Support: 2025 American Heart Association Guidelines for CPR and ECC. Circulation. 2025. doi:10.1161/CIR.0000000000001376 Link
  4. Neumar RW, et al. Part 8: Adult Advanced Cardiovascular Life Support: 2010 AHA Guidelines for CPR and ECC. Circulation. 2010;122:S729-S767. Link
  5. Merck Manual Professional Version: Long QT Syndrome and Torsades de Pointes Ventricular Tachycardia (reviewed September 2024). Link
  6. Umpierrez GE, Davis GM, ElSayed NA, et al. Hyperglycemic Crises in Adults With Diabetes: A Consensus Report. Diabetes Care. 2024;47:1257. doi:10.2337/dci24-0032 Link
  7. Spasovski G, Vanholder R, Allolio B, et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Eur J Endocrinol. 2014;170(3):G1-G47. Link
  8. Hyponatremia Correction and Osmotic Demyelination Syndrome Risk: A Systematic Review and Meta-Analysis. Kidney Med. 2025. doi:10.1016/j.xkme.2024.100953 Link
  9. Potassium Chloride for Injection Concentrate, prescribing information (Hospira). DailyMed, US National Library of Medicine. Link
  10. Potassium Chloride Injection (premixed), prescribing information (ICU Medical). DailyMed. Link
  11. Calcium Chloride Injection 10%, prescribing information (Hospira). DailyMed. Link
  12. Calcium Gluconate Injection, prescribing information (WG Critical Care). DailyMed. Link
  13. Merck Manual Professional Version: Hypokalemia; Hyponatremia; Hypernatremia (Electrolyte Disorders). Link
  14. Merck Manual Professional Version: Hyperkalemia. Link
  15. Merck Manual Professional Version: Hypocalcemia; Hypercalcemia. Link
  16. Merck Manual Professional Version: Hypomagnesemia; Hypermagnesemia. Link
  17. Merck Manual Professional Version: Hypophosphatemia; Hyperphosphatemia. Link
  18. Merck Manual Professional Version: Preeclampsia and Eclampsia. Link
  19. Merck Manual Professional Version: Management of Adverse Effects of Cancer Therapy (tumor lysis syndrome). Link
  20. MedlinePlus Medical Encyclopedia: Calcium blood test (reviewed 11/6/2025), Magnesium blood test (reviewed 2/13/2025) and Phosphorus blood test (reviewed 11/6/2025). US National Library of Medicine. Link
  21. MedlinePlus Medical Encyclopedia: Sodium blood test. US National Library of Medicine. Link
  22. El-Hajj Fuleihan G, et al. Treatment of Hypercalcemia of Malignancy in Adults: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2023;108(3):507-528. Link
  23. da Silva JSV, et al. ASPEN Consensus Recommendations for Refeeding Syndrome. Nutr Clin Pract. 2020;35(2):178-195. Link
  24. Özdemir E, Yılmaz T, Düzenci D. Limited diagnostic utility of albumin-corrected calcium in the intensive care unit: a prospective comparison with ionised calcium. PLOS One. 2026;21(7):e0354233. doi:10.1371/journal.pone.0354233 Link